C.M. Bidwell & Associates »

Silverback Therapeutics shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $491 48 10.23

More positions owned by C.M. Bidwell & Associates

iShares Russell 1000 Index (IWB)
iShares Russell 2000 Index (IWM)
Vanguard Total Stock Market ETF (VTI)
Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
Ishares Tr core strm usbd (ISTB)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Malvern Fds strm infproidx (VTIP)
Schwab U S Broad Market ETF (SCHB)
Dimensional Etf Trust (DFAC)
Schwab Strategic Tr us lrg cap etf (SCHX)
Schwab Strategic Tr 0 (SCHP)

View all positions for C.M. Bidwell & Associates

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
Sr One Capital Management
Franklin Resources
Vanguard Group
BlackRock
K2 Principal Fund
Nextech Invest
State Street Corporation
FMR
Geode Capital Management
Perceptive Advisors
Rubric Capital Management
Royce & Associates

View all funds holding Silverback Therapeutics